|
Workshop on Methods in Supportive Oncology Research
|
5R25CA181000-04
|
$309,257
|
|
TEMEL, JENNIFER
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
|
5R01CA210125-02
|
$656,491
|
|
WOODALL, W
|
KLEIN BUENDEL, INC.
|
|
Weakened spindle checkpoint in vivo: a cause of aneuploidy and cancer in FA?
|
5F30CA200227-02
|
$49,044
|
|
CERABONA, DONNA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Validation of FOXM1 as a new therapeutic target in high-risk myeloma
|
5R21CA187388-02
|
$165,844
|
|
JANZ, SIEGFRIED
|
UNIVERSITY OF IOWA
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-04
|
$379,294
|
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using Single Cell Analysis to identify therapeutic vulnerabilities in leptomeningeal melanoma metastases
|
1R21CA216756-01
|
$187,050
|
|
SMALLEY, KEIRAN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Using markers to improve pancreatic cancer screening and surveillance
|
5U01CA210170-02
|
$953,081
|
|
GOGGINS, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Understanding Uncertainties in Radiomics Studies
|
1R21CA216572-01
|
$174,000
|
|
COURT, LAURENCE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Translational Research Training in Cancer Etiology and Prevention
|
5T32CA186873-04
|
$142,329
|
|
YUAN, JIAN-MIN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Translational control of EMT by the CELF1 RNA Binding Protein
|
5R01CA190467-03
|
$362,569
|
|
NEILSON, JOEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Transforming The Treatment of Tobacco Use in Health Care: Seizing The Potential of the Electronic Health Record to Deliver Comprehensive Chronic Care Treatment for Smoking
|
5R35CA197573-03
|
$888,930
|
|
FIORE, MICHAEL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Training Physician Scientists in Pediatric Oncology
|
5T32CA009659-22
|
$136,153
|
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Training In Cancer Biology
|
5T32CA009135-40
|
$424,344
|
|
SUGDEN, WILLIAM
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Training Grant in Cancer Biology
|
5T32CA186892-02
|
$223,492
|
|
HUNG, MIEN-CHIE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
To the edge of necroptosis and back
|
2R01CA169291-06
|
$426,313
|
|
GREEN, DOUGLAS
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Therapeutic Targeting of Malignant Glioma Stem Cells
|
5R35CA197725-04
|
$916,993
|
|
LESNIAK, MACIEJ
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The role of the PI3K pathway in immune resistance
|
5R01CA187076-04
|
$332,000
|
|
HWU, PATRICK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The role of Mtss1 in Hedgehog-mediated intestinal cancer stem cell function
|
5K08CA198002-03
|
$175,770
|
|
ROPER, JATIN
|
TUFTS MEDICAL CENTER
|
|
The role of FOXO transcriptional factors in TSC-mediated tumorigenesis
|
1R21CA135057-01
|
$171,000
|
$85,500
|
DePinho, Ronald
|
DANA-FARBER CANCER INSTITUTE
|
|
The Role of FKBP38 in tumorigenesis associated with Tsc deficiency
|
1R01CA129821-01A1
|
$281,526
|
$281,526
|
JIANG, YU
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-23
|
$4,865,652
|
$48,657
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPORE
|
5P50CA168505-05
|
$2,278,318
|
|
RINGEL, MATTHEW
|
OHIO STATE UNIVERSITY
|
|
The mTOR and Hippo pathway in cell growth and cancer
|
5R35CA196878-03
|
$912,964
|
|
GUAN, KUN-LIANG
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
The molecular mechanisms of metabolism reprogramming in mutant Kras/Ink4a-driven pancreatic ductal adenocarcinoma
|
1R01CA207031-01A1
|
$366,000
|
|
CHIAO, PAUL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
The molecular mechanism of isocitrate dehydrogenase (lDH) mutations in cancer
|
5R00CA187594-05
|
$219,412
|
|
SOHL, CHRISTAL
|
SAN DIEGO STATE UNIVERSITY
|
|
The mechanism and function of cell competition in tumors
|
5K22CA190440-03
|
$175,424
|
|
LI, WEI
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-04
|
$435,560
|
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Targeting telomerase for melanoma therapeutics
|
5R01CA201312-02
|
$471,448
|
|
SKORDALAKES, EMMANUEL
|
WISTAR INSTITUTE
|
|
Targeting sphingosine kinase 2 for the treatment of multiple myeloma
|
5R01CA197792-03
|
$363,713
|
|
KANG, YUBIN
|
DUKE UNIVERSITY
|
|
TARGETING ROR1 WITH CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
|
5R01CA114536-12
|
$458,731
|
|
RIDDELL, STANLEY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeting protein-protein interactions of Bmi1 oncoprotein
|
5R01CA201204-02
|
$319,688
|
|
GREMBECKA, JOLANTA
|
UNIVERSITY OF MICHIGAN
|
|
Targeting epigenetic regulation to disrupt glioma stem cell maintenance.
|
5F30CA183510-04
|
$49,044
|
|
MILLER, TYLER
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Targeting DNA Base Excision Repair in Acute Myeloid Leukemias
|
1R21CA216551-01
|
$200,970
|
|
LLOYD, R.
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Targeting cell metabolism for preventing and treating metastatic colon cancer
|
1R21CA216604-01
|
$172,913
|
|
JIN, SHENGKAN VICTOR
|
RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL
|
|
Targeting cancer-associated cohesin alterations
|
5F32CA203229-02
|
|
|
REGAL, JOSHUA
|
UNIVERSITY OF BRITISH COLUMBIA
|
|
Targeted Chemoprevention of Flat and Polypoid Colitis-associated Dysplasias
|
5R01CA183301-03
|
$418,613
|
|
CLAPPER, MARGIE
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Take a Break: mHealth-assisted skills building challenge for unmotivated smokers
|
5R01CA190866-03
|
$642,967
|
|
HOUSTON, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Tailored NRT Integrated with Smartphone Behavioral Support
|
5R44CA199920-03
|
$1,000,000
|
|
LEVY, ALAN
|
CHRONO THERAPEUTICS, INC.
|
|
Study the mechanisms underlying common fragile site protection
|
5R01CA187052-03
|
$440,344
|
|
WU, XIAOHUA
|
SCRIPPS RESEARCH INSTITUTE
|
|
Stimuli-responsive crosslinked theranostics against advanced prostate cancer
|
5R01CA199668-03
|
$359,138
|
|
LI, YUANPEI
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
STAT3, G6PD and TrxR as underlying mechanisms for antitumor responses to hirsutinolides
|
1R01CA208851-01A1
|
$671,829
|
|
TURKSON, JAMES
|
UNIVERSITY OF HAWAII AT MANOA
|
|
SPORE: DF/HCC SPORE in GASTROINTESTINAL CANCER
|
5P50CA127003-10
|
$2,293,187
|
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
|
5P50CA168504-05
|
$2,051,965
|
|
WINER, ERIC
|
DANA-FARBER CANCER INST
|
|
Sphingosine-1-phosphate receptor subtype 3 in oncogenic K-Ras mutant-driven lung adenocarcinoma
|
1R21CA216650-01
|
$179,988
|
|
LEE, MENQ-JER
|
WAYNE STATE UNIVERSITY
|
|
Spatially-resolved proteomic mapping of living cells
|
5R01CA186568-05
|
$797,807
|
|
TING, ALICE
|
STANFORD UNIVERSITY
|
|
Social Determinants of Breast Cancer Survivorship
|
5K01CA184288-05
|
$145,257
|
|
DEAN, LORRAINE
|
JOHNS HOPKINS UNIVERSITY
|
|
Small Financial Incentives to Promote Smoking Cessation in Safety Net Hospital Patients
|
5R01CA197314-04
|
$303,797
|
|
KENDZOR, DARLA
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
SLC5A8 is a conditional tumor suppressor in colon linked to dietary fiber content
|
5R01CA190710-03
|
$349,811
|
|
GANAPATHY, VADIVEL
|
TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
|
|
Six2 mediates late-stage metastasis through reversible/irreversible regulation of downstream target genes
|
5F31CA210622-02
|
$31,545
|
|
OLIPHANT, MICHAEL
|
UNIVERSITY OF COLORADO DENVER
|
|
Signal Transduction of Type 1 Interferons in Malignant Cells
|
5R01CA077816-19
|
$298,913
|
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
Total relevant funding to Tuberous Sclerosis for this search: $4,909,703
|